The epidemiological impact and significance of carbapenem resistance in Pseudomonas aeruginosa bloodstream infections: a matched case-case-control analysis.

Authors :: Aviv T
Lazarovitch T
Katz D
Zaidenstein R
Dadon M
Daniel C
Tal-Jasper R
Kaye KS
Marchaim D
Source :: Infection control and hospital epidemiology [Infect Control Hosp Epidemiol] 2018 Oct; Vol. 39 (10), pp. 1262-1265. Date of Electronic Publication: 2018 Aug 14.
Publication Year :: 2018
Abstract: A case-case-control investigation (N = 255 patients) explored the epidemiology of carbapenem-resistant Pseudomonas aeruginosa (CRPA). Recent exposure to carbapenems and a rapidly fatal condition should prompt practitioners to shorten delays in initiating appropriate therapy, which can adversely impact CRPA outcomes, as opposed to the isolated impact of the carbapenem resistance determinant.

Subjects :: Aged
Aged, 80 and over
Bacteremia mortality
Case-Control Studies
Female
Humans
Israel epidemiology
Male
Middle Aged
Pseudomonas Infections mortality
Pseudomonas aeruginosa
Risk Factors
Survival Analysis
Anti-Bacterial Agents pharmacology
Bacteremia epidemiology
Carbapenems pharmacology
Hospital Mortality
Pseudomonas Infections epidemiology
beta-Lactam Resistance

Full Text Access

Tools